Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Invested Capital (2018 - 2025)

CorMedix's Return on Invested Capital history spans 9 years, with the latest figure at 0.35% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 64.0% year-over-year to 0.35%; the TTM value through Dec 2025 reached 0.35%, up 64.0%, while the annual FY2025 figure was 0.56%, N/A changed from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.35% at CorMedix, down from 0.53% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.53% in Q3 2025 and bottomed at 1.0% in Q2 2024.
  • The 4-year median for Return on Invested Capital is 0.52% (2022), against an average of 0.4%.
  • The largest annual shift saw Return on Invested Capital plummeted -33bps in 2021 before it soared 138bps in 2025.
  • A 4-year view of Return on Invested Capital shows it stood at 0.55% in 2021, then fell by -4bps to 0.57% in 2022, then soared by 49bps to 0.29% in 2024, then skyrocketed by 222bps to 0.35% in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Return on Invested Capital are 0.35% (Q4 2025), 0.53% (Q3 2025), and 0.29% (Q4 2024).